Literature DB >> 10207012

gamma-Secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid beta peptides of varying length.

M P Murphy1, L J Hickman, C B Eckman, S N Uljon, R Wang, T E Golde.   

Abstract

gamma-Secretase activity is the final cleavage event that releases the amyloid beta peptide (Abeta) from the beta-secretase cleaved carboxyl-terminal fragment of the amyloid beta protein precursor (APP). No protease responsible for this highly unusual, purportedly intramembranous, cleavage has been definitively identified. We examined the substrate specificity of gamma-secretase by mutating various residues within or adjacent to the transmembrane domain of the APP and then analyzing Abeta production from cells transfected with these mutant APPs by enzyme-linked immunosorbent assay and mass spectrometry. Abeta production was also analyzed from a subset of transmembrane domain APP mutants that showed dramatic shifts in gamma-secretase cleavage in the presence or absence of pepstatin, an inhibitor of gamma-secretase activity. These studies demonstrate that gamma-secretase's cleavage specificity is primarily determined by location of the gamma-secretase cleavage site of APP with respect to the membrane, and that gamma-secretase activity is due to the action of multiple proteases exhibiting both a pepstatin- sensitive activity and a pepstatin-insensitive activity. Given that gamma-secretase is a major therapeutic target in Alzheimer's disease these studies provide important information with respect to the mechanism of Abeta production that will direct efforts to isolate the gamma-secretases and potentially to develop effective therapeutic inhibitors of pathologically relevant gamma-secretase activities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207012     DOI: 10.1074/jbc.274.17.11914

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  The role of presenilins in Alzheimer's disease.

Authors:  G Thinakaran
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  The intramembrane cleavage site of the amyloid precursor protein depends on the length of its transmembrane domain.

Authors:  Stefan F Lichtenthaler; Dirk Beher; Heike S Grimm; Rong Wang; Mark S Shearman; Colin L Masters; Konrad Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 3.  Spotlight on BACE: the secretases as targets for treatment in Alzheimer disease.

Authors:  C Dingwall
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins.

Authors:  Ian V J Murray; Liu Liu; Hiroaki Komatsu; Kunihiro Uryu; Gang Xiao; John A Lawson; Paul H Axelsen
Journal:  J Biol Chem       Date:  2007-01-24       Impact factor: 5.157

5.  Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase.

Authors:  A Mudher; S Chapman; J Richardson; A Asuni; G Gibb; C Pollard; R Killick; T Iqbal; L Raymond; I Varndell; P Sheppard; A Makoff; E Gower; P E Soden; P Lewis; M Murphy; T E Golde; H T Rupniak; B H Anderton; S Lovestone
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

Review 6.  Substrate specificity of gamma-secretase and other intramembrane proteases.

Authors:  A J Beel; C R Sanders
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

7.  Sumoylation of amyloid precursor protein negatively regulates Abeta aggregate levels.

Authors:  Yu-Qian Zhang; Kevin D Sarge
Journal:  Biochem Biophys Res Commun       Date:  2008-07-31       Impact factor: 3.575

8.  γ-Secretase processing and effects of γ-secretase inhibitors and modulators on long Aβ peptides in cells.

Authors:  Yong Ran; Pedro E Cruz; Thomas B Ladd; Abdul H Fauq; Joo In Jung; Julian Matthews; Kevin M Felsenstein; Todd E Golde
Journal:  J Biol Chem       Date:  2013-12-18       Impact factor: 5.157

9.  BACE1 and BACE2 enzymatic activities in Alzheimer's disease.

Authors:  Rachel R Ahmed; Christopher J Holler; Robin L Webb; Feng Li; Tina L Beckett; M Paul Murphy
Journal:  J Neurochem       Date:  2009-12-04       Impact factor: 5.372

10.  A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease.

Authors:  Erik Portelius; Robert A Dean; Mikael K Gustavsson; Ulf Andreasson; Henrik Zetterberg; Eric Siemers; Kaj Blennow
Journal:  Alzheimers Res Ther       Date:  2010-03-29       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.